Concepedia

Hüsün Sheyma Kizilkaya

HS

Statistics

Publications

8

Citations

211

H-Index

8

Active since

2018

Affiliations

University of Copenhagen(Current)

Novo Nordisk Foundation

Copenhagen University Hospital

Frederiksberg Hospital

Novo Nordisk (Denmark)

Hüsün Sheyma Kizilkaya is an author at University of Copenhagen specializing in pharmacology, endocrinology, and signal transduction.

ORCID

Publications per year

2018–2024

8

Publications

8

Loss of Function Glucose-Dependent Insulinotropic Polypeptide Receptor Variants Are Associated With Alterations in BMI, Bone Strength and Cardiovascular Outcomes

Hüsün Sheyma Kizilkaya, Kimmie V. Sørensen, Camilla J. Kibsgaard et al. · Frontiers in Cell and Developmental Biology · 2021 · 45 citations · Full text

, , +17

Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes

Hüsün Sheyma Kizilkaya, Kimmie V. Sørensen, Jakob Sture Madsen et al. · Nature Metabolism · 2024 · 42 citations · Full text

, , +17

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats

Sara Baldassano, Lærke S. Gasbjerg, Hüsün Sheyma Kizilkaya et al. · Frontiers in Endocrinology · 2019 · 32 citations · Full text

, , +17

Investigating GIPR (ant)agonism: A structural analysis of GIP and its receptor

Florent X. Smit, Wijnand J. C. van der Velden, Hüsün Sheyma Kizilkaya et al. · Structure · 2021 · 22 citations · Full text

, , +12

Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin

Kristian Reckzeh, Hüsün Sheyma Kizilkaya, Alexandra S. Helbo et al. · Blood Advances · 2018 · 20 citations · Full text

, , +2

1–5 of 8